ACPU
ASPX

Arrowgrass Capital Partners (US)’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-124,752
Closed -$12.5M – 612
2015
Q1 		$12.5M Buy
+124,752
New +$8.31M 0.19% 72

Arrowgrass Capital Partners (US)'s ASPX Position: Q2 2015 in Review

Arrowgrass Capital Partners (US) sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 124,752 shares — an estimated $12.5M sold.

Arrowgrass Capital Partners (US) first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $12.5M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Arrowgrass Capital Partners (US) reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 124,752 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $12.5M.
  • Arrowgrass Capital Partners (US) first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Arrowgrass Capital Partners (US)'s AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $12.5M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q2 2015, filed 14 Aug 2015.